United States · Federal contract register · Supplier record

DIASORIN INC

Line: In vitro diagnostic substances, reagents, test kits and sets (6550)Register loaded to September 2026Compiled 17 October 2026

DIASORIN INC — United States · Federal contract register · Supplier record: 326 contracts, all years ($46,897,031 · Oct 2000 – Oct 2026); $7.8M since January 2024 (72 contracts · 3 agencies); 20th rank in the line (of 334 suppliers · 0.83%); 6 agencies never served ($2.9M on the line without DIASORIN INC).

Assay record ASY-US-0FUSKR20NH · Cite as: Assay Systems, “DIASORIN INC: 72 government contracts in the United States since 2024”, https://assay-systems.com/register/us/diasorin-inc/

326
contracts, all years
$46,897,031 · Oct 2000 – Oct 2026
$7.8M
since January 2024
72 contracts · 3 agencies
20th
rank in the line
of 334 suppliers · 0.83%
6
agencies never served
$2.9M on the line without DIASORIN INC

Own record by year

2019 onward
$1.0M
$5.5M
$7.6M
$2.4M
$5.7M
$2.7M
$2.9M
$2.2M
20192020202120222023202420252026

Who buys from DIASORIN INC

since January 2024
3agencies
$7.8Mpaid
75.9%top buyer
Department of Veterans Affairs75.9%
$5,949,014
Department of Defense22.9%
$1,790,787
Department of Health and Human Services1.2%
$93,336

Before 2024 only: Department of Agriculture, General Services Administration, National Aeronautics and Space Administration.

Won without a rival

2023-10-01 – 2026-09-15
83uncontested awards
81%of its awards
68without a competition
15single bid

DIASORIN INC won 83 of its 102 public contract awards in United States without a rival from 2023-10-01 to 2026-09-15, worth $6.8M: 68 without a competition and 15 after a competition that drew a single bid. 7 buyers awarded it without a rival, the largest Department of Veterans Affairs with 55.

Buyers: Department of Veterans Affairs (55) · Department of the Air Force (10) · Department of the Army (7) · Defense Health Agency (5) · National Institutes of Health (3) · Centers for Disease Control and Prevention (2)

Every uncontested award of DIASORIN INC · United States: all uncontested awards

The line

since January 2024
$534Mline value
7,757contracts
11agencies
334suppliers
61.1%held by top ten

In vitro diagnostic substances, reagents, test kits and sets (6550)

$229M
$202M
$103M
202420252026Jan–Sep
20thof 334 suppliers
$4,414,051DIASORIN INC in the line
0.83%share of the line
1.0%of $328,152,297 spent by Department of Veterans Affairs
1.0%of $105,567,208 spent by Department of Defense

Agencies that buy the line and never bought from DIASORIN INC

6agencies
51contracts
$2,910,690since January 2024
Department of State21 contracts
$1,650,716
Social Security Administration2 contracts
$574,150
Environmental Protection Agency5 contracts
$327,283
Department of Justice17 contracts
$204,596
Department of the Interior5 contracts
$138,850
Department of Commerce1 contract
$15,095

How the line is bought

by value, since 2024
41%no competition
20%one applicant
0of these to DIASORIN INC
Awarded directly, no competition1,307 contracts
$218,503,818 · 40.9%
Competed, several suppliers applied5,050 contracts
$211,306,251 · 39.5%
Competed, one supplier applied1,400 contracts
$104,531,724 · 19.6%

Contracts reaching their end dates

Oct 2026 – October 2027
534contracts
$121,148,433end by October 2027
102end in September 2027 · $25.8M
5in agencies never served · $836K
$7.9M
$3.5M
$11.1M
$9.0M
$5.4M
$10.0M
$10.8M
$11.4M
$10.2M
$4.6M
$11.5M
$25.8M
Oct 2629 contractsNov 2623 contractsDec 2652 contractsJan 2736 contractsFeb 2737 contractsMar 2757 contractsApr 2740 contractsMay 2739 contractsJun 2745 contractsJul 2722 contractsAug 2752 contractsSep 27102 contracts

Fastest-growing supplier in the line

same line
+135%growth

Supplier UEI PU6HHX2R11C7

2024 to Sep 2026
$42,184,140
2022–2023
$17,936,792

The extract

Every buying office, every contract holder, value, number and end date behind the figures above.

Request extractSee a sample extract

Source: USAspending.gov, U.S. Department of the Treasury, Bureau of the Fiscal Service, usaspending.gov, accessed 30 September 2026.The data is available to copy, adapt, redistribute, or otherwise use for non-commercial or for commercial purposes (USAspending.gov, Licensing); no Dun & Bradstreet data is shown.